We noticed that in 2017 Acta published a registered placebo‐controlled randomized clinical trial (NCT02571296) with a statistically significant positive result.1 This is unusual (as stated by Prior et al).2 Among women with a past history of spontaneous preterm delivery at <37 weeks, 100 mg oral micronized progesterone, 6‐hourly, starting at 14‐18 weeks, significantly reduced the primary outcome of birth before 37 weeks compared with placebo.
|Number of pages||1|
|Journal||Acta Obstetricia et Gynecologica Scandinavica|
|Early online date||8 Dec 2019|
|Publication status||Published - Mar 2020|